Colorectal cancer in the elderly: Is palliative chemotherapy of value?HONECKER, Friedemann; KÖHNE, Claus-Henning; BOKEMEYER, Carsten et al.Drugs & aging. 2003, Vol 20, Num 1, pp 1-11, issn 1170-229X, 11 p.Article

Pharmacokinetics of gemcitabine in a patient with end-stage renal disease: effective clearance of its main metabolite by standard hemodialysis treatmentKIANI, Alexander; KÖHNE, Claus-Henning; FRANZ, Thorsten et al.Cancer chemotherapy and pharmacology. 2003, Vol 51, Num 3, pp 266-270, issn 0344-5704, 5 p.Article

Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC) -gastrointestinal cancer groupVAN CUTSEM, Eric; VAN DE VELDE, Cornelius; ROTH, Arnaud et al.European journal of cancer (1990). 2008, Vol 44, Num 2, pp 182-194, issn 0959-8049, 13 p.Article

Cost-Effectiveness of Targeted Therapy With Cetuximab in Patients With K-ras Wild-Type Colorectal Cancer Presenting With Initially Unresectable Metastases Limited to the Liver in a German SettingASSEBURG, Christian; FRANK, Martin; KOHNE, Claus-Henning et al.Clinical therapeutics. 2011, Vol 33, Num 4, pp 482-497, issn 0149-2918, 16 p.Article

Pooled Safety and Efficacy Analysis Examining the Effect of Performance Status on Outcomes in Nine First-Line Treatment Trials Using Individual Data From Patients With Metastatic Colorectal CancerSARGENT, Daniel J; KÖHNE, Claus Henning; DOUILLARD, Jean-Yves et al.Journal of clinical oncology. 2009, Vol 27, Num 12, pp 1948-1955, issn 0732-183X, 8 p.Article

A randomised phase III intergroup trial comparing high-dose infusional 5-fluorouracil with or without folinic acid with standard bolus 5-fluorouracil/folinic acid in the adjuvant treatment of stage III colon cancer: The Pan-European Trial in Adjuvant Colon Cancer 2 studyKÖHNE, Claus-Henning; BEDENNE, Laurent; WILS, Jacques et al.European journal of cancer (1990). 2013, Vol 49, Num 8, pp 1868-1875, issn 0959-8049, 8 p.Article

Randomized, Placebo-Controlled, Phase III Study of Oxaliplatin, Fluorouracil, and Leucovorin With or Without PTK787/ZK 222584 in Patients With Previously Treated Metastatic Colorectal AdenocarcinomaVAN CUTSEM, Eric; BAJETTA, Emilio; LEBWOHL, David et al.Journal of clinical oncology. 2011, Vol 29, Num 15, pp 2004-2010, issn 0732-183X, 7 p.Article

Does a patient's self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer?EFFICACE, Fabio; BOTTOMLEY, Andrew; COENS, Corneel et al.European journal of cancer (1990). 2006, Vol 42, Num 1, pp 42-49, issn 0959-8049, 8 p.Article

Induction of cellular immune responses against carcinoembryonic antigen in patients with metastatic tumors after vaccination with altered peptide ligand-loaded dendritic cellsBABATZ, Jana; RÖLLIG, Christoph; LÖBEL, Bärbel et al.Cancer immunology and immunotherapy. 2006, Vol 55, Num 3, pp 268-276, issn 0340-7004, 9 p.Article

First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancerKÖHNE, Claus-Henning; HOFHEINZ, Ralf; MINEUR, Laurent et al.Journal of cancer research and clinical oncology. 2012, Vol 138, Num 1, pp 65-72, issn 0171-5216, 8 p.Article

Towards a pan-European consensus on the treatment of patients with colorectal liver metastasesVAN CUTSEM, Eric; NORDLINGER, Bernard; ADAM, Rene et al.European journal of cancer (1990). 2006, Vol 42, Num 14, pp 2212-2221, issn 0959-8049, 10 p.Article

TET2 Mutations in Acute Myeloid Leukemia (AML): Results From a Comprehensive Genetic and Clinical Analysis of the AML Study GroupGAIDZIK, Verena I; PASCHKA, Peter; BENTZ, Martin et al.Journal of clinical oncology. 2012, Vol 30, Num 12, pp 1350-1357, issn 0732-183X, 8 p.Article

Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment GroupNORDLINGER, Bernard; VAN CUTSEM, Eric; GIULIANTE, Felice et al.European journal of cancer (1990). 2007, Vol 43, Num 14, pp 2037-2045, issn 0959-8049, 9 p.Article

Sorafenib in Combination with Oxaliplatin, Leucovorin, and Fluorouracil (Modified FOLFOX6) as First-line Treatment of Metastatic Colorectal Cancer: The RESPECT TrialTABERNERO, Josep; GARCIA-CARBONERO, Rocio; VLADIMIROVA, Liubov et al.Clinical cancer research (Print). 2013, Vol 19, Num 9, pp 2541-2550, issn 1078-0432, 10 p.Article

The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AMLKAYSER, Sabine; DÖHNER, Konstanze; RUMMEL, Mathias et al.Blood. 2011, Vol 117, Num 7, pp 2137-2145, issn 0006-4971, 9 p.Article

Clinical Benefit and Quality of Life in Patients With Advanced Pancreatic Cancer Receiving Gemcitabine Plus Capecitabine Versus Gemcitabine Alone : A Randomized Multicenter Phase III Clinical Trial-SAKK 44/00-CECOG/ PAN.1.3.001BERNHARD, Jürg; DIETRICH, Daniel; BAUER, Jean et al.Journal of clinical oncology. 2008, Vol 26, Num 22, pp 3695-3701, issn 0732-183X, 7 p.Article

Clinical, Molecular, and Prognostic Significance of WHO Type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and Various Other 3q Abnormalities in Acute Myeloid LeukemiaLUGTHART, Sanne; GRÖSCHEL, Stefan; VERHOEF, Gregor et al.Journal of clinical oncology. 2010, Vol 28, Num 24, pp 3890-3898, issn 0732-183X, 9 p.Article